Efficient suppression of minority drug-resistant HIV type 1 (HIV-1) variants present at primary HIV-1 infection by ritonavir-boosted protease inhibitor-containing antiretroviral therapy.

Source:http://linkedlifedata.com/resource/pubmed/id/20196655

J. Infect. Dis. 2010 Apr 1 201 7 1063-71

Download in:

View as

General Info

PMID
20196655